These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1759428)

  • 1. [The level of vasoactive prostanoids in patients with ischemic heart disease in the early period following aortocoronary bypass].
    Bakhoviddinova GSh
    Vrach Delo; 1991 Sep; (9):36-8. PubMed ID: 1759428
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
    Al-Mondhiry H; Pierce WS; Pennock JL
    J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
    Inoue T
    Nihon Ronen Igakkai Zasshi; 1983 Jul; 20(4):294-304. PubMed ID: 6363769
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug modulation of thromboxane A2/prostacyclin balance and lipid peroxidation in patients with coronary artery disease].
    Zhao X; Zhang YH; Feng HF
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):476-8, 510-1. PubMed ID: 2086017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological correction of disorders of the prostacyclin- thromboxane balance in ischemic heart disease: problems and prospects].
    Markov KhM
    Kardiologiia; 1990 Apr; 30(4):111-8. PubMed ID: 2118578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia].
    Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP
    Sov Med; 1988; (4):3-6. PubMed ID: 3043710
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiplatelet and anticoagulant therapy after coronary bypass.
    Phillips SJ; Kongtahworn C; Zeff RH; Beshany SE
    N Engl J Med; 1980 Apr; 302(15):866. PubMed ID: 6965762
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].
    Loeliger EA
    Schweiz Med Wochenschr; 1988 Mar; 118(12):447-9. PubMed ID: 3259724
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulation].
    Pfisterer M; Jockers G; Burkart F; Schmitt HE; Wolff G; Skarvan K; Stulz P; Hasse J; Grädel E
    Schweiz Med Wochenschr; 1987 Oct; 117(43):1688-92. PubMed ID: 3501162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostaglandins and ischemic cardiopathy].
    Strano A; Davì G
    Cardiologia; 1985 Apr; 30(4):261-4. PubMed ID: 3914359
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans.
    Faymonville ME; Deby-Dupont G; Larbuisson R; Deby C; Bodson L; Limet R; Lamy M
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):858-66. PubMed ID: 3520158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac release of prostacyclin and thromboxane A2 during coronary revascularization.
    Teoh KH; Fremes SE; Weisel RD; Christakis GT; Teasdale SJ; Madonik MM; Ivanov J; Mee AV; Wong PY
    J Thorac Cardiovasc Surg; 1987 Jan; 93(1):120-6. PubMed ID: 3540456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotypic familial correlations of prostacyclin and thromboxane A2 levels in children and adolescents with or without hereditary predisposition to ischemic heart disease].
    Akimov EV
    Kardiologiia; 1992 May; 32(5):41-3. PubMed ID: 1405259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [THe development of systems for the early rehabilitation of patients with ischemic heart disease following aortocoronary bypass].
    Kniazeva TA; Nosova AV; Zubkova SM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (4):7-10. PubMed ID: 9424839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets and coronary heart disease: therapy update.
    Mehta JL
    Geriatrics; 1982 May; 37(5):129-34, 139. PubMed ID: 7040169
    [No Abstract]   [Full Text] [Related]  

  • 17. [Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts].
    Nomura F; Hirose H; Matsuda H; Nakano S; Shirakura R; Ohtani M; Kaneko M; Sasako Y; Kawashima Y; Kuzuya T
    Kyobu Geka; 1985 Jan; 38(1):46-9. PubMed ID: 3884863
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of ibustrin on early aortocoronary bypass patency.
    Pirk J; Rohn V; Peregrin J
    Cor Vasa; 1990; 32(3):258-62. PubMed ID: 2209029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ischemic heart disease and prostanoids: pathogenesis and its implications for treatment].
    Aoyama T; Yui Y; Hattori R; Kawai C
    Nihon Rinsho; 1990 Jun; 48(6):1229-33. PubMed ID: 2117082
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting.
    Bybee KA; Powell BD; Valeti U; Rosales AG; Kopecky SL; Mullany C; Wright RS
    Circulation; 2005 Aug; 112(9 Suppl):I286-92. PubMed ID: 16159833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.